FDA Approves Another Migraine Drug That Might Not Cost A Lot...For Now

FDA Approves Another Migraine Drug That Might Not Cost A Lot...For Now  Newsy FDA Greenlights Galcanezumab (Emgality) for Migraine Prevention  Medscape FDA Approves Third Injectable Migraine Drug  Pain News NetworkFull coverage

from Health - Google News https://ift.tt/2zEUNqB